Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis
Background of the article: Biologics are modern immunomodulatory drugs, whose use in the treatment of psoriasis has led to remarkable results in psoriatic patients. The administration of these agents in special population groups, such as patients with chronic infections and renal impairment, as well...
Main Authors: | Kerasia-Maria Plachouri, Sophia Georgiou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-10-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2018.1544413 |
Similar Items
-
Dupilumab in pediatric dermatology
by: Kerasia-Maria Plachouri, et al.
Published: (2022-02-01) -
The management of biologics in dermatologic patients in the 2019-nCoV era
by: Kerasia-Maria Plachouri, et al.
Published: (2020-05-01) -
New aspects of the pathogenesis of psoriasis
by: Alexander S. Zhukov, et al.
Published: (2022-09-01) -
Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review
by: Kerasia-Maria Plachouri, et al.
Published: (2019-02-01) -
Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
by: Kerasia-Maria Plachouri, et al.
Published: (2023-06-01)